Aerie Pharmaceuticals Stock News

Aerie Pharmaceuticals Inc (NASDAQ:AERI) shares shot up 5.9% during trading on Tuesday . The stock traded as high as $12.95 and last traded at $12.71, 926,536 shares changed hands during trading. A dec

Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients wi

Franklin Resources Inc. acquired a new position in shares of Aerie Pharmaceuticals Inc (NASDAQ:AERI) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Com

Victory Capital Management Inc. lifted its stake in Aerie Pharmaceuticals Inc (NASDAQ:AERI) by 17.7% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange

SpringWorks Therapeutics (NASDAQ:SWTX) and Aerie Pharmaceuticals (NASDAQ:AERI) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the st

Aerie Pharmaceuticals Inc (NASDAQ:AERI) was down 7% during mid-day trading on Friday . The stock traded as low as $11.92 and last traded at $12.17, approximately 1,067,629 shares changed hands during

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...

Alliancebernstein L.P. boosted its holdings in Aerie Pharmaceuticals Inc (NASDAQ:AERI) by 21.6% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission.

Credit Suisse AG reduced its stake in shares of Aerie Pharmaceuticals Inc (NASDAQ:AERI) by 85.4% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchan

Needham analyst Serge Belanger maintained a Buy rating on Aerie Pharma (AERI) today and set a price target of $40.00. The company's shares closed last

Needham analyst Serge Belanger maintained a Buy rating on Aerie Pharma (AERI – Research Report) today and set a price

After Needham and Oppenheimer gave Aerie Pharma (NASDAQ: AERI) a Buy rating last month, the company received another Buy, this time from Mizuho

After Needham and Oppenheimer gave Aerie Pharma (NASDAQ: AERI) a Buy rating last month, the company received another Buy, this

Bank of New York Mellon Corp raised its stake in Aerie Pharmaceuticals Inc (NASDAQ:AERI) by 3.2% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Ex